Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate
- PMID: 19748778
- DOI: 10.1016/j.bmcl.2009.08.080
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate
Abstract
We prepared three discreet cohorts of potent non-nucleoside HIV reverse transcriptase inhibitors (NNRTIs) based on the recently reported 3-cyanophenoxypyrazole lead 3. Several of these compounds displayed very promising anti-HIV activity in vitro, safety, pharmacokinetic and pharmaceutical profiles. We describe our analysis and conclusions leading to the selection of alcohol 5 (UK-453,061, lersivirine) for clinical development.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical